世界のヒトインターロイキン-2(IL-2)市場2020-2025:50000U、100000U、200000U、500000U、100万U、200万U

LP Informationが発行した調査報告書(LPI20JN05122)
◆英語タイトル:Global Human Interleukin-2 (IL-2) Market Growth 2020-2025
◆商品コード:LPI20JN05122
◆発行会社(リサーチ会社):LP Information
◆発行日:2020年6月
◆ページ数:184
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥380,640見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥570,960見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「ヒトインターロイキン-2(IL-2)の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、50000U、100000U、200000U、500000U、100万U、200万Uなど、用途別には、組換えインターフェロン、組換えインターロイキン、天然生物製剤、毒免疫、遺伝子治療、モノクローナル抗体などに区分してまとめた調査レポートです。ヒトインターロイキン-2(IL-2)のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ヒトインターロイキン-2(IL-2)の世界市場概要(サマリー)
・ヒトインターロイキン-2(IL-2)の企業別販売量・売上
・ヒトインターロイキン-2(IL-2)の企業別市場シェア
・ヒトインターロイキン-2(IL-2)の世界市場規模 2015年-2020年:種類別(50000U、100000U、200000U、500000U、100万U、200万U)
・ヒトインターロイキン-2(IL-2)の世界市場規模 2015年-2020年:用途別(組換えインターフェロン、組換えインターロイキン、天然生物製剤、毒免疫、遺伝子治療、モノクローナル抗体)
・ヒトインターロイキン-2(IL-2)の米州市場規模(アメリカ、カナダ、メキシコなど)
・ヒトインターロイキン-2(IL-2)のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ヒトインターロイキン-2(IL-2)の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトインターロイキン-2(IL-2)の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトインターロイキン-2(IL-2)市場の成長要因・課題・動向
・ヒトインターロイキン-2(IL-2)の世界市場予測 2021年-2025年
・ヒトインターロイキン-2(IL-2)の米州市場予測(アメリカ、カナダ、メキシコなど)
・ヒトインターロイキン-2(IL-2)のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ヒトインターロイキン-2(IL-2)の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトインターロイキン-2(IL-2)の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトインターロイキン-2(IL-2)の世界市場予測:種類別(50000U、100000U、200000U、500000U、100万U、200万U)
・ヒトインターロイキン-2(IL-2)の世界市場予測:用途別(組換えインターフェロン、組換えインターロイキン、天然生物製剤、毒免疫、遺伝子治療、モノクローナル抗体)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Human Interleukin-2 (IL-2) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Interleukin-2 (IL-2) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Interleukin-2 (IL-2) market by type, application, key manufacturers and key regions and countries.

This study considers the Human Interleukin-2 (IL-2) value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
50000 U
100000 U
200000 U
500000 U
1 Million U
2 Million U

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Recombinant Interferon
Recombinant Interleukin
Natural Biological Products
Poison Immune
Gene Therapy
Monoclonal Antibody

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Jiangsu Jinsili Pharmaceutical
BMS
AbbVie Inc
Alkermes Plc
Schering-Plough
Philogen
APT Therapeutics
Sinopharm
Mabtech Limited
Beijing Sihuan Biological Pharmaceutical
Shenzhen Kexing Biological Engineering
Beijing Sanyuan Gene Pharmaceutical
Shenyang Sansheng Pharmaceutical
Shanghai Huaxin Biological high-tech
Shandong Quangang Pharmaceutical
Xiamen Tebao Biological Engineering
Beijing Yuance Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shanghai Sanwei Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical
Chengdu huashen Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Human Interleukin-2 (IL-2) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Interleukin-2 (IL-2) market by identifying its various subsegments.
Focuses on the key global Human Interleukin-2 (IL-2) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Interleukin-2 (IL-2) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Interleukin-2 (IL-2) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Interleukin-2 (IL-2) Consumption 2015-2025
2.1.2 Human Interleukin-2 (IL-2) Consumption CAGR by Region
2.2 Human Interleukin-2 (IL-2) Segment by Type
2.2.1 50000 U
2.2.2 100000 U
2.2.3 200000 U
2.2.4 500000 U
2.2.5 1 Million U
2.2.6 2 Million U
2.3 Human Interleukin-2 (IL-2) Consumption by Type
2.3.1 Global Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Interleukin-2 (IL-2) Sale Price by Type (2015-2020)
2.4 Human Interleukin-2 (IL-2) Segment by Application
2.4.1 Recombinant Interferon
2.4.2 Recombinant Interleukin
2.4.3 Natural Biological Products
2.4.4 Poison Immune
2.4.5 Gene Therapy
2.4.6 Monoclonal Antibody
2.5 Human Interleukin-2 (IL-2) Consumption by Application
2.5.1 Global Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Interleukin-2 (IL-2) Value and Market Share by Type (2015-2020)
2.5.3 Global Human Interleukin-2 (IL-2) Sale Price by Type (2015-2020)

3 Global Human Interleukin-2 (IL-2) by Company
3.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Company
3.1.1 Global Human Interleukin-2 (IL-2) Sales by Company (2018-2020)
3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2018-2020)
3.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Company
3.2.1 Global Human Interleukin-2 (IL-2) Revenue by Company (2018-2020)
3.2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2018-2020)
3.3 Global Human Interleukin-2 (IL-2) Sale Price by Company
3.4 Global Human Interleukin-2 (IL-2) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Interleukin-2 (IL-2) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Interleukin-2 (IL-2) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Interleukin-2 (IL-2) by Regions
4.1 Human Interleukin-2 (IL-2) by Regions
4.2 Americas Human Interleukin-2 (IL-2) Consumption Growth
4.3 APAC Human Interleukin-2 (IL-2) Consumption Growth
4.4 Europe Human Interleukin-2 (IL-2) Consumption Growth
4.5 Middle East & Africa Human Interleukin-2 (IL-2) Consumption Growth

5 Americas
5.1 Americas Human Interleukin-2 (IL-2) Consumption by Countries
5.1.1 Americas Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020)
5.1.2 Americas Human Interleukin-2 (IL-2) Value by Countries (2015-2020)
5.2 Americas Human Interleukin-2 (IL-2) Consumption by Type
5.3 Americas Human Interleukin-2 (IL-2) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Interleukin-2 (IL-2) Consumption by Regions
6.1.1 APAC Human Interleukin-2 (IL-2) Consumption by Regions (2015-2020)
6.1.2 APAC Human Interleukin-2 (IL-2) Value by Regions (2015-2020)
6.2 APAC Human Interleukin-2 (IL-2) Consumption by Type
6.3 APAC Human Interleukin-2 (IL-2) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Human Interleukin-2 (IL-2) by Countries
7.1.1 Europe Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020)
7.1.2 Europe Human Interleukin-2 (IL-2) Value by Countries (2015-2020)
7.2 Europe Human Interleukin-2 (IL-2) Consumption by Type
7.3 Europe Human Interleukin-2 (IL-2) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human Interleukin-2 (IL-2) by Countries
8.1.1 Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Interleukin-2 (IL-2) Value by Countries (2015-2020)
8.2 Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Type
8.3 Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Interleukin-2 (IL-2) Distributors
10.3 Human Interleukin-2 (IL-2) Customer

11 Global Human Interleukin-2 (IL-2) Market Forecast
11.1 Global Human Interleukin-2 (IL-2) Consumption Forecast (2021-2025)
11.2 Global Human Interleukin-2 (IL-2) Forecast by Regions
11.2.1 Global Human Interleukin-2 (IL-2) Forecast by Regions (2021-2025)
11.2.2 Global Human Interleukin-2 (IL-2) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Interleukin-2 (IL-2) Forecast by Type
11.8 Global Human Interleukin-2 (IL-2) Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Human Interleukin-2 (IL-2) Product Offered
12.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 Jiangsu Jinsili Pharmaceutical
12.2.1 Company Information
12.2.2 Human Interleukin-2 (IL-2) Product Offered
12.2.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Jiangsu Jinsili Pharmaceutical Latest Developments
12.3 BMS
12.3.1 Company Information
12.3.2 Human Interleukin-2 (IL-2) Product Offered
12.3.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 BMS Latest Developments
12.4 AbbVie Inc
12.4.1 Company Information
12.4.2 Human Interleukin-2 (IL-2) Product Offered
12.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 AbbVie Inc Latest Developments
12.5 Alkermes Plc
12.5.1 Company Information
12.5.2 Human Interleukin-2 (IL-2) Product Offered
12.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Alkermes Plc Latest Developments
12.6 Schering-Plough
12.6.1 Company Information
12.6.2 Human Interleukin-2 (IL-2) Product Offered
12.6.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Schering-Plough Latest Developments
12.7 Philogen
12.7.1 Company Information
12.7.2 Human Interleukin-2 (IL-2) Product Offered
12.7.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Philogen Latest Developments
12.8 APT Therapeutics
12.8.1 Company Information
12.8.2 Human Interleukin-2 (IL-2) Product Offered
12.8.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 APT Therapeutics Latest Developments
12.9 Sinopharm
12.9.1 Company Information
12.9.2 Human Interleukin-2 (IL-2) Product Offered
12.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sinopharm Latest Developments
12.10 Mabtech Limited
12.10.1 Company Information
12.10.2 Human Interleukin-2 (IL-2) Product Offered
12.10.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Mabtech Limited Latest Developments
12.11 Beijing Sihuan Biological Pharmaceutical
12.11.1 Company Information
12.11.2 Human Interleukin-2 (IL-2) Product Offered
12.11.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Beijing Sihuan Biological Pharmaceutical Latest Developments
12.12 Shenzhen Kexing Biological Engineering
12.12.1 Company Information
12.12.2 Human Interleukin-2 (IL-2) Product Offered
12.12.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Shenzhen Kexing Biological Engineering Latest Developments
12.13 Beijing Sanyuan Gene Pharmaceutical
12.13.1 Company Information
12.13.2 Human Interleukin-2 (IL-2) Product Offered
12.13.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Beijing Sanyuan Gene Pharmaceutical Latest Developments
12.14 Shenyang Sansheng Pharmaceutical
12.14.1 Company Information
12.14.2 Human Interleukin-2 (IL-2) Product Offered
12.14.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Shenyang Sansheng Pharmaceutical Latest Developments
12.15 Shanghai Huaxin Biological high-tech
12.15.1 Company Information
12.15.2 Human Interleukin-2 (IL-2) Product Offered
12.15.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Shanghai Huaxin Biological high-tech Latest Developments
12.16 Shandong Quangang Pharmaceutical
12.16.1 Company Information
12.16.2 Human Interleukin-2 (IL-2) Product Offered
12.16.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shandong Quangang Pharmaceutical Latest Developments
12.17 Xiamen Tebao Biological Engineering
12.17.1 Company Information
12.17.2 Human Interleukin-2 (IL-2) Product Offered
12.17.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Xiamen Tebao Biological Engineering Latest Developments
12.18 Beijing Yuance Pharmaceutical
12.18.1 Company Information
12.18.2 Human Interleukin-2 (IL-2) Product Offered
12.18.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Beijing Yuance Pharmaceutical Latest Developments
12.19 Beijing Shuanglu Pharmaceutical
12.19.1 Company Information
12.19.2 Human Interleukin-2 (IL-2) Product Offered
12.19.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Beijing Shuanglu Pharmaceutical Latest Developments
12.20 Shanghai Sanwei Biotechnology
12.20.1 Company Information
12.20.2 Human Interleukin-2 (IL-2) Product Offered
12.20.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Shanghai Sanwei Biotechnology Latest Developments
12.21 Shanghai Pharma Group
12.21.1 Company Information
12.21.2 Human Interleukin-2 (IL-2) Product Offered
12.21.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Shanghai Pharma Group Latest Developments
12.22 Guangdong Xinghao Pharmaceutical
12.22.1 Company Information
12.22.2 Human Interleukin-2 (IL-2) Product Offered
12.22.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Guangdong Xinghao Pharmaceutical Latest Developments
12.23 Chengdu huashen Biotechnology
12.23.1 Company Information
12.23.2 Human Interleukin-2 (IL-2) Product Offered
12.23.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Chengdu huashen Biotechnology Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Interleukin-2 (IL-2) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 50000 U
Table 5. Major Players of 100000 U
Table 6. Major Players of 200000 U
Table 7. Major Players of 500000 U
Table 8. Major Players of 1 Million U
Table 9. Major Players of 2 Million U
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Table 12. Global Human Interleukin-2 (IL-2) Revenue by Type (2015-2020) ($ million)
Table 13. Global Human Interleukin-2 (IL-2) Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Human Interleukin-2 (IL-2) Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Table 17. Global Human Interleukin-2 (IL-2) Value by Application (2015-2020)
Table 18. Global Human Interleukin-2 (IL-2) Value Market Share by Application (2015-2020)
Table 19. Global Human Interleukin-2 (IL-2) Sale Price by Application (2015-2020)
Table 20. Global Human Interleukin-2 (IL-2) Sales by Company (2017-2019) (KG)
Table 21. Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2017-2019)
Table 22. Global Human Interleukin-2 (IL-2) Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2017-2019)
Table 24. Global Human Interleukin-2 (IL-2) Sale Price by Company (2017-2019)
Table 25. Global Human Interleukin-2 (IL-2) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Human Interleukin-2 (IL-2) Products Offered
Table 27. Human Interleukin-2 (IL-2) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Human Interleukin-2 (IL-2) Consumption by Regions 2015-2020 (KG)
Table 29. Global Human Interleukin-2 (IL-2) Consumption Market Share by Regions 2015-2020
Table 30. Global Human Interleukin-2 (IL-2) Value by Regions 2015-2020 ($ Millions)
Table 31. Global Human Interleukin-2 (IL-2) Value Market Share by Regions 2015-2020
Table 32. Americas Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020) (KG)
Table 33. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Countries (2015-2020)
Table 34. Americas Human Interleukin-2 (IL-2) Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Human Interleukin-2 (IL-2) Value Market Share by Countries (2015-2020)
Table 36. Americas Human Interleukin-2 (IL-2) Consumption by Type (2015-2020) (KG)
Table 37. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Table 38. Americas Human Interleukin-2 (IL-2) Consumption by Application (2015-2020) (KG)
Table 39. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Table 40. APAC Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020) (KG)
Table 41. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Countries (2015-2020)
Table 42. APAC Human Interleukin-2 (IL-2) Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Human Interleukin-2 (IL-2) Value Market Share by Regions (2015-2020)
Table 44. APAC Human Interleukin-2 (IL-2) Consumption by Type (2015-2020) (KG)
Table 45. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Table 46. APAC Human Interleukin-2 (IL-2) Consumption by Application (2015-2020) (KG)
Table 47. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Table 48. Europe Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020) (KG)
Table 49. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Countries (2015-2020)
Table 50. Europe Human Interleukin-2 (IL-2) Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Human Interleukin-2 (IL-2) Value Market Share by Countries (2015-2020)
Table 52. Europe Human Interleukin-2 (IL-2) Consumption by Type (2015-2020) (KG)
Table 53. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Table 54. Europe Human Interleukin-2 (IL-2) Consumption by Application (2015-2020) (KG)
Table 55. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Countries (2015-2020) (KG)
Table 57. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Human Interleukin-2 (IL-2) Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Human Interleukin-2 (IL-2) Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Type (2015-2020) (KG)
Table 61. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Human Interleukin-2 (IL-2) Consumption by Application (2015-2020) (KG)
Table 63. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Table 64. Human Interleukin-2 (IL-2) Distributors List
Table 65. Human Interleukin-2 (IL-2) Customer List
Table 66. Global Human Interleukin-2 (IL-2) Consumption Forecast by Countries (2021-2025) (KG)
Table 67. Global Human Interleukin-2 (IL-2) Consumption Market Forecast by Regions
Table 68. Global Human Interleukin-2 (IL-2) Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Human Interleukin-2 (IL-2) Value Market Share Forecast by Regions
Table 70. Global Human Interleukin-2 (IL-2) Consumption Forecast by Type (2021-2025) (KG)
Table 71. Global Human Interleukin-2 (IL-2) Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Human Interleukin-2 (IL-2) Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Human Interleukin-2 (IL-2) Value Market Share Forecast by Type (2021-2025)
Table 74. Global Human Interleukin-2 (IL-2) Consumption Forecast by Application (2021-2025) (KG)
Table 75. Global Human Interleukin-2 (IL-2) Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Human Interleukin-2 (IL-2) Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Human Interleukin-2 (IL-2) Value Market Share Forecast by Application (2021-2025)
Table 78. Roche Product Offered
Table 79. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. Roche Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu Jinsili Pharmaceutical Product Offered
Table 84. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 85. Jiangsu Jinsili Pharmaceutical Main Business
Table 86. Jiangsu Jinsili Pharmaceutical Latest Developments
Table 87. Jiangsu Jinsili Pharmaceutical Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 88. BMS Product Offered
Table 89. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 90. BMS Main Business
Table 91. BMS Latest Developments
Table 92. BMS Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie Inc Product Offered
Table 94. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 95. AbbVie Inc Main Business
Table 96. AbbVie Inc Latest Developments
Table 97. AbbVie Inc Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 98. Alkermes Plc Product Offered
Table 99. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 100. Alkermes Plc Main Business
Table 101. Alkermes Plc Latest Developments
Table 102. Alkermes Plc Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 103. Schering-Plough Product Offered
Table 104. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 105. Schering-Plough Main Business
Table 106. Schering-Plough Latest Developments
Table 107. Schering-Plough Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 108. Philogen Product Offered
Table 109. Philogen Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 110. Philogen Main Business
Table 111. Philogen Latest Developments
Table 112. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 113. APT Therapeutics Product Offered
Table 114. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 115. APT Therapeutics Main Business
Table 116. APT Therapeutics Latest Developments
Table 117. APT Therapeutics Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 118. Sinopharm Product Offered
Table 119. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 120. Sinopharm Main Business
Table 121. Sinopharm Latest Developments
Table 122. Sinopharm Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 123. Mabtech Limited Product Offered
Table 124. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 125. Mabtech Limited Main Business
Table 126. Mabtech Limited Latest Developments
Table 127. Mabtech Limited Basic Information, Company Total Revenue (in $ million), Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 128. Beijing Sihuan Biological Pharmaceutical Product Offered
Table 129. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 130. Beijing Sihuan Biological Pharmaceutical Main Business
Table 131. Beijing Sihuan Biological Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Beijing Sihuan Biological Pharmaceutical Latest Developments
Table 133. Shenzhen Kexing Biological Engineering Product Offered
Table 134. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 135. Shenzhen Kexing Biological Engineering Main Business
Table 136. Shenzhen Kexing Biological Engineering Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. Shenzhen Kexing Biological Engineering Latest Developments
Table 138. Beijing Sanyuan Gene Pharmaceutical Product Offered
Table 139. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 140. Beijing Sanyuan Gene Pharmaceutical Main Business
Table 141. Beijing Sanyuan Gene Pharmaceutical Latest Developments
Table 142. Beijing Sanyuan Gene Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 143. Shenyang Sansheng Pharmaceutical Product Offered
Table 144. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 145. Shenyang Sansheng Pharmaceutical Main Business
Table 146. Shenyang Sansheng Pharmaceutical Latest Developments
Table 147. Shenyang Sansheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai Huaxin Biological high-tech Product Offered
Table 149. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 150. Shanghai Huaxin Biological high-tech Main Business
Table 151. Shanghai Huaxin Biological high-tech Latest Developments
Table 152. Shanghai Huaxin Biological high-tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 153. Shandong Quangang Pharmaceutical Product Offered
Table 154. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 155. Shandong Quangang Pharmaceutical Main Business
Table 156. Shandong Quangang Pharmaceutical Latest Developments
Table 157. Shandong Quangang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 158. Xiamen Tebao Biological Engineering Product Offered
Table 159. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 160. Xiamen Tebao Biological Engineering Main Business
Table 161. Xiamen Tebao Biological Engineering Latest Developments
Table 162. Xiamen Tebao Biological Engineering Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Yuance Pharmaceutical Product Offered
Table 164. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 165. Beijing Yuance Pharmaceutical Main Business
Table 166. Beijing Yuance Pharmaceutical Latest Developments
Table 167. Beijing Yuance Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 168. Beijing Shuanglu Pharmaceutical Product Offered
Table 169. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 170. Beijing Shuanglu Pharmaceutical Main Business
Table 171. Beijing Shuanglu Pharmaceutical Latest Developments
Table 172. Beijing Shuanglu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 173. Shanghai Sanwei Biotechnology Product Offered
Table 174. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 175. Shanghai Sanwei Biotechnology Main Business
Table 176. Shanghai Sanwei Biotechnology Latest Developments
Table 177. Shanghai Sanwei Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 178. Shanghai Pharma Group Product Offered
Table 179. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 180. Shanghai Pharma Group Main Business
Table 181. Shanghai Pharma Group Latest Developments
Table 182. Shanghai Pharma Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 183. Guangdong Xinghao Pharmaceutical Product Offered
Table 184. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 185. Guangdong Xinghao Pharmaceutical Main Business
Table 186. Guangdong Xinghao Pharmaceutical Latest Developments
Table 187. Guangdong Xinghao Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 188. Chengdu huashen Biotechnology Product Offered
Table 189. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 190. Chengdu huashen Biotechnology Main Business
Table 191. Chengdu huashen Biotechnology Latest Developments
Table 192. Chengdu huashen Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Human Interleukin-2 (IL-2)
Figure 2. Human Interleukin-2 (IL-2) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Interleukin-2 (IL-2) Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Human Interleukin-2 (IL-2) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 50000 U
Figure 7. Product Picture of 100000 U
Figure 8. Product Picture of 200000 U
Figure 9. Product Picture of 500000 U
Figure 10. Product Picture of 1 Million U
Figure 11. Product Picture of 2 Million U
Figure 12. Global Human Interleukin-2 (IL-2) Consumption Market Share by Type (2015-2020)
Figure 13. Global Human Interleukin-2 (IL-2) Value Market Share by Type (2015-2020)
Figure 14. Human Interleukin-2 (IL-2) Consumed in Recombinant Interferon
Figure 15. Global Human Interleukin-2 (IL-2) Market: Recombinant Interferon (2015-2020) (KG)
Figure 16. Global Human Interleukin-2 (IL-2) Market: Recombinant Interferon (2015-2020) ($ Millions)
Figure 17. Human Interleukin-2 (IL-2) Consumed in Recombinant Interleukin
Figure 18. Global Human Interleukin-2 (IL-2) Market: Recombinant Interleukin (2015-2020) (KG)
Figure 19. Global Human Interleukin-2 (IL-2) Market: Recombinant Interleukin (2015-2020) ($ Millions)
Figure 20. Human Interleukin-2 (IL-2) Consumed in Natural Biological Products
Figure 21. Global Human Interleukin-2 (IL-2) Market: Natural Biological Products (2015-2020) (KG)
Figure 22. Global Human Interleukin-2 (IL-2) Market: Natural Biological Products (2015-2020) ($ Millions)
Figure 23. Human Interleukin-2 (IL-2) Consumed in Poison Immune
Figure 24. Global Human Interleukin-2 (IL-2) Market: Poison Immune (2015-2020) (KG)
Figure 25. Global Human Interleukin-2 (IL-2) Market: Poison Immune (2015-2020) ($ Millions)
Figure 26. Human Interleukin-2 (IL-2) Consumed in Gene Therapy
Figure 27. Global Human Interleukin-2 (IL-2) Market: Gene Therapy (2015-2020) (KG)
Figure 28. Global Human Interleukin-2 (IL-2) Market: Gene Therapy (2015-2020) ($ Millions)
Figure 29. Human Interleukin-2 (IL-2) Consumed in Monoclonal Antibody
Figure 30. Global Human Interleukin-2 (IL-2) Consumption Market Share by Application (2015-2020)
Figure 31. Global Human Interleukin-2 (IL-2) Value Market Share by Application (2015-2020)
Figure 32. Global Human Interleukin-2 (IL-2) Sales Market Share by Company in 2017
Figure 33. Global Human Interleukin-2 (IL-2) Sales Market Share by Company in 2019
Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company in 2017
Figure 35. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company in 2019
Figure 36. Global Human Interleukin-2 (IL-2) Sale Price by Company in 2019
Figure 37. Global Human Interleukin-2 (IL-2) Consumption Market Share by Regions 2015-2020
Figure 38. Global Human Interleukin-2 (IL-2) Value Market Share by Regions 2015-2020
Figure 39. Americas Human Interleukin-2 (IL-2) Consumption 2015-2020 (KG)
Figure 40. Americas Human Interleukin-2 (IL-2) Value 2015-2020 ($ Millions)
Figure 41. APAC Human Interleukin-2 (IL-2) Consumption 2015-2020 (KG)
Figure 42. APAC Human Interleukin-2 (IL-2) Value 2015-2020 ($ Millions)
Figure 43. Europe Human Interleukin-2 (IL-2) Consumption 2015-2020 (KG)
Figure 44. Europe Human Interleukin-2 (IL-2) Value 2015-2020 ($ Millions)
Figure 45. Middle East & Africa Human Interleukin-2 (IL-2) Consumption 2015-2020 (KG)
Figure 46. Middle East & Africa Human Interleukin-2 (IL-2) Value 2015-2020 ($ Millions)
Figure 47. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Countries in 2019
Figure 48. Americas Human Interleukin-2 (IL-2) Value Market Share by Countries in 2019
Figure 49. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Type in 2019
Figure 50. Americas Human Interleukin-2 (IL-2) Consumption Market Share by Application in 2019
Figure 51. United States Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 52. United States Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 53. Canada Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 54. Canada Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 55. Mexico Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 56. Mexico Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 57. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Countries in 2019
Figure 58. APAC Human Interleukin-2 (IL-2) Value Market Share by Regions in 2019
Figure 59. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Type in 2019
Figure 60. APAC Human Interleukin-2 (IL-2) Consumption Market Share by Application in 2019
Figure 61. China Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 62. China Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 63. Japan Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 64. Japan Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 65. Korea Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 66. Korea Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 67. Southeast Asia Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 68. Southeast Asia Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 69. India Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 70. India Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 71. Australia Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 72. Australia Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 73. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Countries in 2019
Figure 74. Europe Human Interleukin-2 (IL-2) Value Market Share by Countries in 2019
Figure 75. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Type in 2019
Figure 76. Europe Human Interleukin-2 (IL-2) Consumption Market Share by Application in 2019
Figure 77. Germany Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 78. Germany Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 79. France Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 80. France Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 81. UK Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 82. UK Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 83. Italy Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 84. Italy Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 85. Russia Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 86. Russia Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 87. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Countries in 2019
Figure 88. Middle East & Africa Human Interleukin-2 (IL-2) Value Market Share by Countries in 2019
Figure 89. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Type in 2019
Figure 90. Middle East & Africa Human Interleukin-2 (IL-2) Consumption Market Share by Application in 2019
Figure 91. Egypt Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 92. Egypt Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 93. South Africa Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 94. South Africa Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 95. Israel Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 96. Israel Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 97. Turkey Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 98. Turkey Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 99. GCC Countries Human Interleukin-2 (IL-2) Consumption Growth 2015-2020 (KG)
Figure 100. GCC Countries Human Interleukin-2 (IL-2) Value Growth 2015-2020 ($ Millions)
Figure 101. Global Human Interleukin-2 (IL-2) Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 102. Global Human Interleukin-2 (IL-2) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 103. Americas Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 104. Americas Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 105. APAC Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 106. APAC Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 107. Europe Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 108. Europe Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 109. Middle East & Africa Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 110. Middle East & Africa Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 111. United States Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 112. United States Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 113. Canada Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 114. Canada Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 115. Mexico Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 116. Mexico Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 117. Brazil Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 118. Brazil Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 119. China Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 120. China Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 121. Japan Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 122. Japan Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 123. Korea Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 124. Korea Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 125. Southeast Asia Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 126. Southeast Asia Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 127. India Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 128. India Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 129. Australia Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 130. Australia Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 131. Germany Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 132. Germany Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 133. France Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 134. France Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 135. UK Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 136. UK Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 137. Italy Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 138. Italy Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 139. Russia Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 140. Russia Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 141. Spain Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 142. Spain Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 143. Egypt Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 144. Egypt Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 145. South Africa Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 146. South Africa Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 147. Israel Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 148. Israel Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 149. Turkey Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 150. Turkey Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 151. GCC Countries Human Interleukin-2 (IL-2) Consumption 2021-2025 (KG)
Figure 152. GCC Countries Human Interleukin-2 (IL-2) Value 2021-2025 ($ Millions)
Figure 153. Roche Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 154. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 155. BMS Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 156. AbbVie Inc Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 157. Alkermes Plc Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 158. Schering-Plough Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 159. Philogen Human Interleukin-2 (IL-2) Market Share (2018-2020)
Figure 160. APT Therapeutics Human Interleukin-2 (IL-2) Market Share (2018-2020)_x

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒトインターロイキン-2(IL-2)市場2020-2025:50000U、100000U、200000U、500000U、100万U、200万U(Global Human Interleukin-2 (IL-2) Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆